Home/Filings/4/0000950170-25-004166
4//SEC Filing

Cavalier Jason 4

Accession 0000950170-25-004166

CIK 0001327273other

Filed

Jan 9, 7:00 PM ET

Accepted

Jan 10, 4:15 PM ET

Size

5.2 KB

Accession

0000950170-25-004166

Insider Transaction Report

Form 4
Period: 2024-01-08
Cavalier Jason
Chief Financial Officer
Transactions
  • Award

    Common Stock

    2025-01-08+420,000520,000 total
Footnotes (1)
  • [F1]Represents an award of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in three substantially equal installments occurring on July 1, 2025, January 1, 2026 and July 1, 2026, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date.

Documents

1 file

Issuer

Lyra Therapeutics, Inc.

CIK 0001327273

Entity typeother

Related Parties

1
  • filerCIK 0001883290

Filing Metadata

Form type
4
Filed
Jan 9, 7:00 PM ET
Accepted
Jan 10, 4:15 PM ET
Size
5.2 KB